Sarada Srinivasa Raghavan

Sarada Srinivasa Raghavan

Active Director Director DIN 06641146
DIN 06641146 First appointment Aug 2013 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Aug 2013
Shareholding value •••• Premium profile

About Sarada Srinivasa Raghavan

Data last updated:

Sarada Srinivasa Raghavan is a Director at Emmessar Biotech And Nutrition Ltd (since 2013), Designated Partner at Emmessar Global Partners Llp (since 2024) and Director at Qyuradyne Biotech Private Limited (since 2023). The companies operate in Healthcare, Paper and Chemicals and Materials. The 3 current companies with reported revenue have a combined latest revenue of ₹3.78 Cr; the largest is Emmessar Biotech And Nutrition Ltd at ₹2.62 Cr (FY 2025). Earlier, Sarada Srinivasa Raghavan was a Whole-Time Director at Emmessar Technologies Private Limited (2013–2025) and Designated Partner at Herbs In Sync Llp (from 2020).

DIN 06641146
Primary Designation Director
Industry Healthcare
First Appointment 12 Aug 2013
Oldest Company Age 34 yrs
Largest company Emmessar Biotech And Nutrition Ltd · ₹2.62 Cr (FY 2025)
Combined revenue ₹3.78 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Emmessar Biotech And Nutrition Ltd L24110MH1992PLC065942
Director12 Aug 20131992₹2.62 Cr (FY 2025)Active
Designated Partner13 Nov 20242024₹1.15 Cr (FY 2026)Active
Qyuradyne Biotech Private Limited U21001MH2023PTC403125
Director17 May 20232023₹95,323 (FY 2024)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Whole-Time Director12 Aug 20131984₹21.93 Cr (FY 2025)Active
Designated Partner04 Nov 20202020Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Herbs In Sync Llp
Emmessar Biotech And Nutrition Ltd
Emmessar Global Partners Llp
Qyuradyne Biotech Private Limited
Premium access

Shareholding and investment profile for Sarada Srinivasa Raghavan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sarada Srinivasa Raghavan

Sarada Srinivasa Raghavan currently holds 3 directorships: Emmessar Biotech And Nutrition Ltd (Director, since 12 Aug 2013, revenue ₹2.62 Cr (FY 2025)); Emmessar Global Partners Llp (Designated Partner, since 13 Nov 2024, revenue ₹1.15 Cr (FY 2026)); Qyuradyne Biotech Private Limited (Director, since 17 May 2023, revenue ₹95,323 (FY 2024)).

Sarada Srinivasa Raghavan was first appointed on 12 Aug 2013 as Director at Emmessar Biotech And Nutrition Ltd. The most recent appointment on record is 13 Nov 2024 at Emmessar Global Partners Llp.

The 3 current companies of Sarada Srinivasa Raghavan that report revenue have a combined latest revenue of ₹3.78 Cr: Emmessar Biotech And Nutrition Ltd ₹2.62 Cr (FY 2025); Emmessar Global Partners Llp ₹1.15 Cr (FY 2026); Qyuradyne Biotech Private Limited ₹95,323 (FY 2024).

Sarada Srinivasa Raghavan held 2 earlier board appointments: Emmessar Technologies Private Limited (Whole-Time Director, 12 Aug 2013 to 14 Jun 2025); Herbs In Sync Llp (Designated Partner, from 04 Nov 2020).

The current boards of Sarada Srinivasa Raghavan's companies include Anuradha Srinivasa Raghavan (Emmessar Biotech And Nutrition Ltd), Dinesh Kumar Deora (Emmessar Biotech And Nutrition Ltd), Jeyavel Balaiah Nadar (Emmessar Biotech And Nutrition Ltd), Jeyavel Balaiah Nadar (Emmessar Biotech And Nutrition Ltd), Milind Sitaram Desai (Emmessar Biotech And Nutrition Ltd), Priyanka Om Prakash Sharma (Emmessar Biotech And Nutrition Ltd), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available